Vertos Medical completed enrollment in the MOTION study of the mild® Procedure for the treatment of lumbar spinal stenosis (LSS).
The novel, the prospective, randomized, controlled study enrolled 150 patients at 19 U.S. sites, for a two-year follow-up, collecting clinically validated, patient-reported pain and function outcome measures, as well as the real-world quality of life data using Fitbit activity trackers. This is the second large multi-center randomized controlled trial of the procedure.
mild removes the cause of LSS through a portal the size of a baby aspirin. It requires no implants, no general anesthesia, no stitches, and no overnight hospital stay. The procedure has been performed on more than 25,000 patients, and study data have shown clinically meaningful and statistically significant mobility improvement and pain reduction, with no serious complications.
Vertos Medical completed enrollment in the MOTION study of the mild® Procedure for the treatment of lumbar spinal stenosis (LSS).
The novel, the prospective, randomized, controlled study enrolled 150 patients at 19 U.S. sites, for a two-year follow-up, collecting clinically validated, patient-reported pain and function outcome...
Vertos Medical completed enrollment in the MOTION study of the mild® Procedure for the treatment of lumbar spinal stenosis (LSS).
The novel, the prospective, randomized, controlled study enrolled 150 patients at 19 U.S. sites, for a two-year follow-up, collecting clinically validated, patient-reported pain and function outcome measures, as well as the real-world quality of life data using Fitbit activity trackers. This is the second large multi-center randomized controlled trial of the procedure.
mild removes the cause of LSS through a portal the size of a baby aspirin. It requires no implants, no general anesthesia, no stitches, and no overnight hospital stay. The procedure has been performed on more than 25,000 patients, and study data have shown clinically meaningful and statistically significant mobility improvement and pain reduction, with no serious complications.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
